GoPath Diagnostics

Full-service cancer genetics, molecular and anatomic pathology diagnostics laboratory.

[GoPath Diagnostics @GoPathLabs]

As #BladderCancerAwarenessMonth comes to a close, we want to take a moment to recognize everyone working to change the future of this disease. This May, we are proud to join @AACR in shining a light on bladder cancer & the ongoing progress being made.

🔗 https://t.co/I6F8kTPy8i

[GoPath Diagnostics @GoPathLabs]

Wishing everyone a meaningful Memorial Day from the GoPath team. 🇺🇸 Today, we take a moment to honor the brave men & women who gave their lives for this country & the freedoms we hold dear. Our hearts go out to every family who carries the weight of that loss each & every day.

[GoPath Diagnostics @GoPathLabs]

From beignets to breakthroughs, New Orleans does it all! We will be at ADA 2026, Booth 2220, showcasing DiabetesNow, our 16-gene panel for identifying monogenic diabetes. Discover how DiabetesNow can bring clarity to the most complex diabetes cases.
🔗 https://t.co/zZ3QWtgpIB

[GoPath Diagnostics @GoPathLabs]

From the exhibit floor to the nation's capital, AUA 2026 was a moment we will not forget! 🔬

Our team loved connecting with so many brilliant minds & walking you through our latest innovations.

Visit our website to explore everything we have to offer!
https://t.co/nzDG5APdwu

[GoPath Diagnostics @GoPathLabs]

From the monuments to the microscope — AUA is officially here! 🏛️

Find us at booth 3515 to explore our ProstateNow germline panel & Triplet Approach to Managing Cancer.

[DigitCells @DigitCells]

Washington D.C. runs on big decisions — and we're here to help you make the right one. AUA Day 1 starts now!

Find us featured inside @GoPathLabs' booth #3515 to see our TWO-D system live and discover how it's revolutionizing biopsy processing from collection to analysis

[GoPath Diagnostics @GoPathLabs]

GoPath Diagnostics partners with @OncoAssure Ltd. to bring OncoAssure Prostate to U.S. clinicians. This genomic+clinical tool shows 4.4× higher biochemical recurrence risk & 9.7× more adverse pathology findings. See us at AUA 2026, Booth 3515.

Read more: https://t.co/Sfh861iqvc

[GoPath Diagnostics @GoPathLabs]

Today, we join the global community in recognizing World Ovarian Cancer Day. We are proud to stand alongside patients, caregivers, and advocates working toward better outcomes for women everywhere.

Learn more about Ovarian Cancer from @WOCCnews: https://t.co/pm6xzCaMV5

[GoPath Diagnostics @GoPathLabs]

The Big Easy is calling☎️

Join us at the ADA Scientific Sessions, where we'll showcase DiabetesNow, our 16-gene panel designed to identify monogenic diabetes causes that are often missed. See how DiabetesNow can change the way you approach diabetes!

🔗 https://t.co/zZ3QWtgpIB

[GoPath Diagnostics @GoPathLabs]

This May, we recognize #BladderCancerAwarenessMonth & the millions of lives this disease has impacted. With over 84,000 new cases expected in the US in 2026, bladder cancer is far more common than many people realize.

Learn more from the @AmericanCancer https://t.co/OfebViDDfb

[GoPath Diagnostics @GoPathLabs]

From risk assessment to treatment decisions, we're bringing it all to AUA 2026.

Join us at Booth 3515, where our team will be walking through ProstateNow & the Triplet Approach—an end-to-end cancer management strategy built around germline testing, CGP, & MRD testing.

[GoPath Diagnostics @GoPathLabs]

We'll be at the 31st Annual #ExecutiveWarCollege, one of our favorite gatherings of lab leaders who want to move their operations forward.

If you're working through margin pressure, send-out costs, turnaround times, digital pathology adoption, or more, we'd love to connect.

[DigitCells @DigitCells]

We're counting down to AUA 2026 in Washington, D.C. 🗓️
If biopsy processing efficiency is on your radar, you won't want to miss TWO-D, featured inside the @GoPathLabs booth (#3515). Come by, see it in action, & let's talk about what it could look like in your workflow.

[GoPath Diagnostics @GoPathLabs]

🏛️ We're heading to the nation's capital!

Find us at Booth 3515 at the AUA Annual Conference, where we'll be showcasing ProstateNow®, along with our Triplet Approach to Managing Cancer—integrating hereditary testing, CGP, & MRD to support personalized care.

[GoPath Diagnostics @GoPathLabs]

Tomorrow at AACR 2026, we're excited to present new data on CDH17 expression in gastric cancer, a target generating significant momentum in the era of antibody-drug conjugates & precision oncology.

📋 Section 41, Board 17
📅 April 22 | 9 AM – 12 PM (PT)

https://t.co/PVzoD3dBTn

[GoPath Diagnostics @GoPathLabs]

It's Lab Week, & we're kicking it off right! 🎉 Behind every diagnosis, every treatment decision, & every moment of clarity for a patient, a lab professional is making it happen. This week, we're shining the spotlight where it belongs. 🧬🔬
#LabWeek

[GoPath Diagnostics @GoPathLabs]

From the Capitol to the clinic, innovation starts here. 🏛���

Join us at AUA 2026 in Washington, D.C.
📅 May 15–17 | 📍 Booth 3515

We’ll be showcasing ProstateNow®, our germline prostate cancer panel, along with our Triplet Approach to Managing Cancer!

[GoPath Diagnostics @GoPathLabs]

April is Cancer Prevention & Early Detection Month, a time to raise awareness about routine screenings & healthy behaviors that can reduce risk. @Preventcancer has put together a range of resources, including a plan tool, an awareness toolkit, & more!

🔗 https://t.co/Dhd4FfyT32

[GoPath Diagnostics @GoPathLabs]

USCAP 2026 brought together some of the sharpest minds in pathology, and we were glad to be part of it at the GoPath booth.

[GoPath Diagnostics @GoPathLabs]

For the first time in over 15 years, prostate cancer is projected to surpass breast cancer in new US diagnoses in 2026. This is a significant milestone that raises questions about funding, awareness, & screening across all communities.

Read more: https://t.co/pLdJW6VN6O